| Synergy of radiotherapy and a cancer vaccine for the treatment of HPV-associated head and neck cancer M Mondini, M Nizard, T Tran, L Mauge, M Loi, C Clémenson, D Dugue, ... Molecular cancer therapeutics 14 (6), 1336-1345, 2015 | 91 | 2015 |
| Artificial Intelligence in radiotherapy: state of the art and future directions G Francolini, I Desideri, G Stocchi, V Salvestrini, LP Ciccone, P Garlatti, ... Medical Oncology 37, 1-9, 2020 | 70 | 2020 |
| Pre-disease and pre-surgery BMI, weight loss and sarcopenia impact survival of resected lung cancer independently of tumor stage P Icard, O Schussler, M Loi, A Bobbio, A Mansuet Lupo, M Wislez, ... Cancers 12 (2), 266, 2020 | 54 | 2020 |
| Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review P Bonomo, M Loi, I Desideri, E Olmetto, CD Paoli, F Terziani, D Greto, ... Critical Reviews in Oncology/Hematology 120, 98-110, 2017 | 53 | 2017 |
| Robotic stereotactic retreatment for biochemical control in previously irradiated patients affected by recurrent prostate cancer M Loi, V Di Cataldo, G Simontacchi, B Detti, P Bonomo, L Masi, I Desideri, ... Clinical Oncology 30 (2), 93-100, 2018 | 52 | 2018 |
| Application of radiomics for the prediction of radiation-induced toxicity in the IMRT era: current state-of-the-art I Desideri, M Loi, G Francolini, C Becherini, L Livi, P Bonomo Frontiers in oncology 10, 1708, 2020 | 50 | 2020 |
| Stereotactic body radiation therapy and abiraterone acetate for patients affected by oligometastatic castrate-resistant prostate cancer: a randomized phase II trial (ARTO) G Francolini, AG Allegra, B Detti, V Di Cataldo, S Caini, A Bruni, ... Journal of Clinical Oncology 41 (36), 5561-5568, 2023 | 48 | 2023 |
| Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? P Bonomo, D Greto, I Desideri, M Loi, V Di Cataldo, E Orlandi, ... Oral oncology 93, 1-7, 2019 | 45 | 2019 |
| Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus BA Jereczek-Fossa, G Marvaso, M Zaffaroni, SG Gugliandolo, D Zerini, ... Cancer treatment reviews 98, 102206, 2021 | 44 | 2021 |
| Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a … I Desideri, G Francolini, C Becherini, F Terziani, C Delli Paoli, E Olmetto, ... Medical Oncology 34, 1-5, 2017 | 44 | 2017 |
| A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome MA Teriaca, M Loi, M Suker, F Eskens, CHJ van Eijck, JJ Nuyttens Radiotherapy and Oncology 155, 232-236, 2021 | 43 | 2021 |
| A PPAR-gamma agonist protects from radiation-induced intestinal toxicity M Mangoni, M Sottili, C Gerini, I Desideri, C Bastida, S Pallotta, ... United European gastroenterology journal 5 (2), 218-226, 2017 | 42 | 2017 |
| Stereotactic radiotherapy after incomplete transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: a Phase III Trial … T Comito, M Loi, C Franzese, E Clerici, D Franceschini, M Badalamenti, ... Current Oncology 29 (11), 8802-8813, 2022 | 41 | 2022 |
| Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) P Bonomo, I Desideri, M Loi, M Mangoni, M Sottili, L Marrazzo, ... Clinical and translational radiation oncology 9, 42-47, 2018 | 41 | 2018 |
| Locoregional control and survival after lymph node SBRT in oligometastatic disease M Loi, M Frelinghuysen, ND Klass, E Oomen-De Hoop, PV Granton, ... Clinical & experimental metastasis 35, 625-633, 2018 | 38 | 2018 |
| Stereotactic ablative radiotherapy as an alternative to lobectomy in patients with medically operable stage I NSCLC: a retrospective, multicenter analysis V Scotti, A Bruni, G Francolini, M Perna, P Vasilyeva, M Loi, ... Clinical lung cancer 20 (1), e53-e61, 2019 | 36 | 2019 |
| The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications P Icard, L Simula, L Fournel, K Leroy, A Lupo, D Damotte, MC Charpentier, ... Drug Resistance Updates 63, 100852, 2022 | 35 | 2022 |
| Neurotensin expression and outcome of malignant pleural mesothelioma M Alifano, M Loi, S Camilleri-Broet, S Dupouy, JF Régnard, P Forgez Biochimie 92 (2), 164-170, 2010 | 35 | 2010 |
| Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma F Pasqualetti, N Montemurro, I Desideri, M Loi, N Giannini, G Gadducci, ... Acta Neurologica Belgica, 1-6, 2022 | 34 | 2022 |
| Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma? P Icard, L Simula, Z Wu, D Berzan, P Sogni, A Dohan, R Dautry, ... Drug Resistance Updates 59, 100790, 2021 | 33 | 2021 |